Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 91.7 USD -0.09% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Haemonetics Corp
Total Equity Peer Comparison

Comparables:
XRAY
ICUI
ALGN
LNTH
MMSI

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Total Equity
$878.9m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
1%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Total Equity
$2.5B
CAGR 3-Years
-21%
CAGR 5-Years
-13%
CAGR 10-Years
0%
ICU Medical Inc
NASDAQ:ICUI
Total Equity
$2B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
15%
Align Technology Inc
NASDAQ:ALGN
Total Equity
$3.9B
CAGR 3-Years
4%
CAGR 5-Years
25%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Equity
$1.2B
CAGR 3-Years
33%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Total Equity
$1.3B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
12%

See Also

What is Haemonetics Corp's Total Equity?
Total Equity
878.9m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Total Equity amounts to 878.9m USD.

What is Haemonetics Corp's Total Equity growth rate?
Total Equity CAGR 10Y
1%

Over the last year, the Total Equity growth was -2%. The average annual Total Equity growth rates for Haemonetics Corp have been 8% over the past three years , 9% over the past five years , and 1% over the past ten years .

Back to Top